12:00 AM
 | 
Apr 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Valeant Pharmaceuticals, Atlantis S.A. de C.V. deal

Valeant will acquire assets from branded generic company Atlantis, including gastrointestinal, analgesics and anti-inflammatory products for about $71 million....

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >